HIGHLIGHTS
- who: Anouk K. M. Claessens from the (UNIVERSITY) have published the Article: The influence on quality of life of intermittent scheduling in first- and second-line chemotherapy of patients with HER2-negative advanced breast cancer, in the Journal: (JOURNAL)
- what: The aim was to estimate differences in changes from baseline between intermittent and continuous treatment. [8] Here the authors report on the prospectively planned QoL analyses. To prevent the few cases with very long followup measures to exert an unduly great influence on the models, the authors determined the 90th percentile of the maximum follow . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.